HoldsUp

Ben Bikman

Dr. Ben Bikman is a metabolic health specialist who focuses on metabolic dysfunction and insulin resistance. His work examines how lifestyle factors such as diet, exercise, and sleep influence metabolic health and can help reverse insulin resistance. He also evaluates the use and impact of weight loss medications, including Ozempic and other GLP-1 agonists.

96 claims checked on air: 17 context 13 contradicted 9 overstated 48 supported 9 unverified

What they said on air - context

0:09:09needs contextmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Polycystic ovary syndrome (PCOS) is the most common cause of female infertility.

"polycystic ovary syndrome, the most common infertility in women" (said at 0:09:09)

The claim is broadly accurate but requires specific qualification. Polycystic ovary syndrome (PCOS) is established in clinical literature as the most common cause of anovulatory (ovulatory dysfunction) infertility in women, rather than the leading cause of all female infertility across all etiologies (which also include tubal disease, endometriosis, and diminished ovarian reserve).

0:09:09needs contexthighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Breast cancer is the most common cancer in women, and prostate cancer is the most common cancer in men.

"breast and prostate cancers, the two most common cancers in women and men respectively." (said at 0:09:09)

Breast cancer is indeed the most commonly diagnosed cancer among women both globally and regionally. However, whether prostate cancer is the most common cancer in men depends on the geographic population: globally, lung cancer is the most frequently diagnosed cancer in men (followed by prostate cancer), whereas in the United States and many high-income countries, prostate cancer is the most frequently diagnosed non-cutaneous cancer among men.

0:26:38needs contextmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Lowering insulin increases daily resting energy expenditure by 200 to 500 calories.

"a higher metabolic rate by several hundred calories a day when insulin goes down. So the body's just burning a little hotter. The engine is revving higher. So the overall energy expenditure is up, again, by 200 to 500 calories a day." (said at 0:26:38)

The speaker's figures of 200 to ~500 calories per day come from controlled feeding trials evaluating the carbohydrate-insulin model of obesity during weight-loss maintenance. In a randomized trial of 164 adults (Ebbeling et al., 2018), lowering dietary carbohydrate increased total energy expenditure (TEE) by 209 kcal/day in intention-to-treat analysis (278 kcal/day per protocol), and by 308 to 478 kcal/day among participants in the highest tertile of baseline insulin secretion. A subsequent meta-analysis of 29 controlled-feeding studies found that trials lasting longer than 2.5 weeks showed a mean increase of 135 kcal/day on lower-carbohydrate diets. However, this effect applies to total daily energy expenditure (TEE) during weight-loss maintenance rather than resting energy expenditure (REE) alone (which shows smaller changes), and the magnitude and universality of this metabolic advantage remain an area of ongoing debate.

0:33:25needs contextmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Studies in the European Journal of Clinical Nutrition showed that a high-carbohydrate, high-saturated-fat diet produced the worst insulin resistance and insulin signaling outcomes.

"it was some groups in Europe in the European Journal of Clinical Nutrition where they had, in the context of a high-carb diet and then manipulating the saturation of fats, the high-carb and high-saturated fat was the worst for insulin resistance and insulin signaling." (said at 0:33:25)

The speaker accurately describes the findings of landmark European dietary intervention research, though the primary multicenter trial was published in Diabetologia (the KANWU study) rather than the European Journal of Clinical Nutrition. In the randomized controlled KANWU trial (n=162 healthy adults), replacing monounsaturated fatty acids with saturated fatty acids significantly impaired insulin sensitivity (-10%), with the impairment concentrated in individuals consuming a total fat intake below the median (<37% of total energy, corresponding to a higher background carbohydrate intake, where insulin sensitivity was 12.5% lower on the saturated fat diet and 8.8% higher on the monounsaturated diet).

0:46:12needs contextmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Skeletal muscle accounts for roughly 80% of glucose uptake during glucose clearance.

"When if someone's wearing their CGM and they see the glucose come up and down, 80% of that coming down is what's going in to fuel the muscle." (said at 0:46:12)

Under conditions of high physiological hyperinsulinemia (such as during hyperinsulinemic-euglycemic clamp studies), skeletal muscle is well established as the primary site of peripheral insulin-mediated glucose disposal, accounting for approximately 70–80% of total body glucose uptake. However, applying this figure directly to ordinary postprandial glucose curves observed on a continuous glucose monitor (CGM) requires qualification. Following meal ingestion, postprandial glucose homeostasis involves multiple concurrent processes: suppression of endogenous hepatic glucose production, splanchnic (hepatic and gut) glucose uptake, and peripheral disposal across muscle and adipose tissue, meaning skeletal muscle accounts for a smaller proportion (typically 30–50%) of total postprandial glucose clearance than the 80% measured under clamp conditions.

1:15:37needs contexthighDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Cholesterol synthesis pathways produce an essential component of the mitochondrial electron transport system.

"cholesterol is a precursor to an essential component of the electron transport system. And so, it's no surprise that if people are waging war on cholesterol synthesis, the mitochondria may suffer." (said at 1:15:37)

The statement is biochemically accurate regarding the pathway and its physiological consequences, but contains a slight chemical misstatement: cholesterol itself is not the precursor to components of the electron transport chain. Rather, the mevalonate pathway—the biosynthetic pathway responsible for producing cholesterol—branches off upstream at intermediate isoprenoids (such as farnesyl pyrophosphate) to synthesize ubiquinone (coenzyme Q10), an essential electron carrier in the mitochondrial respiratory chain. Consequently, pharmacological inhibition of cholesterol synthesis using HMG-CoA reductase inhibitors (statins) decreases the production of mevalonate and downstream coenzyme Q10, which can contribute to mitochondrial dysfunction and statin-associated muscle symptoms.

1:16:55needs contextmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Atypical antipsychotics with the suffix '-apine' promote weight gain, likely mediated by hypothalamic insulin resistance that reduces satiety signaling.

"And then just for the sake of time, perhaps I just mention the atypical antipsychotics. Any drug that ends with an -apine at the end of it, the suffix being -apine, is generally going to promote weight gain. That's probably through a central insulin resistance of the hypothalamus. When the hypothalamus becomes insulin resistant, you have a reduced satiety signal and the person's just going to start eating more." (said at 1:16:55)

Atypical antipsychotics ending in the suffix '-apine' (notably clozapine, olanzapine, and quetiapine) carry the highest risk of weight gain and metabolic disruption among psychiatric medications. These agents act centrally within the hypothalamus, disrupting satiety signaling, appetite neuropeptides, and central insulin/glucose pathways. However, framing hypothalamic insulin resistance as the primary driver of increased food intake oversimplifies the mechanism: the dominant, well-established pharmacological triggers of antipsychotic-induced hyperphagia are antagonism of hypothalamic histamine H1 and serotonin 5-HT2C receptors and subsequent hypothalamic AMPK activation, alongside central and peripheral metabolic disturbances.

1:38:50needs contextlowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

A study found that South Asian men have subcutaneous adipocytes that are approximately four times larger volumetrically than Caucasian men matched for body size and body fat percentage.

"there's one paper I'm recalling where it took Caucasian men and South Asian men and did an adipose subcutaneous biopsy, and it found that the average South Asian man had adipocytes that were about four times larger volumetrically than the fat cells in the Caucasian at the same body size, same body fat percent." (said at 1:38:50)

The speaker accurately references a study comparing subcutaneous abdominal adipose tissue biopsies between South Asian and Caucasian men (Abate et al., 2007, PMID 17726542). The study found that South Asian men had subcutaneous abdominal adipocyte cross-sectional areas more than twice as large as Caucasian men (3,491 ± 1,393 µm² vs 1,648 ± 864 µm²), which corresponds mathematically to approximately a 3-fold difference in cell volume. However, while the groups were matched for age and BMI, they were not matched for total body fat percentage (South Asian men had significantly higher body fat percentage at 22% vs 15%), though differences in adipocyte size persisted when comparing subgroups matched for subcutaneous abdominal fat mass.

1:46:07needs contextmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

C-reactive protein is a better predictor of heart disease than LDL cholesterol.

"C-reactive protein is a better predictor of heart disease than LDL cholesterol is." (said at 1:46:07)

The claim stems from landmark prospective cohort findings (such as the Women's Health Study of 27,939 women), which found that baseline high-sensitivity C-reactive protein (hs-CRP) exhibited a steeper relative risk gradient across quintiles (RR up to 2.3) for first cardiovascular events than LDL cholesterol (RR up to 1.5) and concluded CRP was a stronger predictor. However, broader multi-cohort individual-participant meta-analyses (e.g., the Emerging Risk Factors Collaboration across >240,000 participants) demonstrate that while CRP is an independent predictor, its addition to standard risk models containing cholesterol metrics provides modest incremental discrimination (increasing the C-index by ~0.0039). Furthermore, LDL cholesterol is an established causal factor in atherogenesis, whereas CRP is a marker of vascular and systemic inflammation, making them complementary rather than mutually exclusive risk markers.

1:47:10needs contextvery lowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

4-HNE, a peroxidation metabolite of linoleic acid, inhibits the hyperplasia potential of fat cells and forces hypertrophic fat growth.

"Specifically, when linoleic acid is taken into the cell, one of its peroxide metabolites that it can turn into is a molecule called 4-HNE. And 4-HNE has been shown to inhibit the fat cell's potential for hyperplasia, thus forcing the fat cell to only go down hypertrophy." (said at 1:47:10)

4-Hydroxynonenal (4-HNE) is a well-established lipid peroxidation byproduct of omega-6 polyunsaturated fatty acids, including linoleic acid. In vitro studies using human adipose-derived stem cells, subcutaneous preadipocytes, and cell lines demonstrate that 4-HNE exposure inhibits adipogenic differentiation (the hyperplasia pathway of adipose tissue). When the formation of new fat cells from precursors is impaired, adipose tissue expansion under positive energy balance is driven predominantly by the enlargement (hypertrophy) of existing adipocytes. However, this model is based on cell culture and ex vivo tissue biopsy mechanisms rather than clinical or in vivo whole-body outcome trials.

1:49:05needs contextvery lowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Dr. Stephen Cunnane's research documented that rapid oxidation of linoleic acid enables the brain to synthesize its own ketones.

"Even Dr. Stephen Cunnane, this incredible man, just a delightful individual, he's done a lot of work documenting the fact that linoleic acid, when it's allowed to just be burned for fuel, burns so high and so rapid that it create—it allows the brain to create its own ketones." (said at 1:49:05)

Dr. Stephen Cunnane's research documented that 18-carbon polyunsaturated fatty acids, including linoleic acid and alpha-linolenic acid, are predominantly metabolized via rapid beta-oxidation rather than being preserved intact. In animal tracer studies (suckling rats and neonatal monkeys), Cunnane and colleagues showed that the oxidized carbon skeletons from linoleate readily generate ketones and acetyl-CoA, which the developing brain utilizes as primary substrates for in situ de novo synthesis of brain cholesterol and fatty acids (carbon recycling). However, this research primarily characterizes linoleate as a systemic ketogenic precursor feeding neonatal brain lipid synthesis rather than demonstrating that the adult human brain directly oxidizes linoleic acid to produce ketones for its own general energetic needs.

1:52:12needs contextmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Dr. Christopher Ramsden at the NIH published research showing that soybean oil has become the leading source of fat calories in the human diet.

"Dr. Christopher Ramsden at the NIH a number of years ago published a report finding that soybean oil has become the number one consumed source of fat calories in the human diet." (said at 1:52:12)

Dr. Christopher Ramsden and colleagues at the NIH co-authored a landmark 2011 study analyzing historical food disappearance data in the United States from 1909 to 1999 (Blasbalg et al., Am J Clin Nutr). They found that per capita consumption of soybean oil increased more than 1,000-fold over the 20th century, becoming by far the largest source of dietary linoleic acid and added fat in the American diet. However, the study specifically evaluated the United States diet using USDA economic disappearance data, rather than the global 'human diet'.

2:03:00needs contextmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Patients on semaglutide undergoing general anesthesia have been found to retain food in their stomach despite fasting for 24 hours.

"like people who go through general surgery and have to be put under for general anesthesia, they found that normally you tell the person, "Don't eat for 24 hours," and their stomach's empty, so they're not going to vomit food up while they're asleep. But they found that if people were on semaglutide, the food was still there and they would still have food in their stomach even though they hadn't eaten for 24 hours." (said at 2:03:00)

The core claim is backed by clinical research: multiple prospective gastric ultrasound and endoscopic studies demonstrate that patients taking semaglutide frequently retain solid food and increased residual gastric content before general anesthesia or sedation, despite adhering to fasting protocols. However, standard preoperative fasting guidelines typically require 6 to 8 hours of fasting for solid food prior to elective surgery, rather than a mandatory 24-hour fast, though semaglutide-induced delayed gastric emptying can cause solid food to remain in the stomach well past standard fasting windows.

2:29:40needs contextlowDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

A recently published study found that the risk of developing blindness is more than double in patients taking high-dose GLP-1 receptor agonists.

"with GLP-1, in fact, it's worth noting another paper was just published this week finding that the risk of blindness doubles—more than doubles—in people on high-dose GLP-1s. Paper was just published. So you look at the degree of blindness that occurs in adults, and those using the drug, it was more than twice the risk of developing blindness." (said at 2:29:40)

The speaker is referencing a widely publicized July 2024 observational cohort study published in JAMA Ophthalmology (Hathaway et al.), which investigated the link between semaglutide (a GLP-1 receptor agonist) and nonarteritic anterior ischemic optic neuropathy (NAION), a condition causing sudden optic nerve-related vision loss. That study found a substantially elevated risk of NAION among patients prescribed semaglutide compared to non-GLP-1 medications, both in type 2 diabetes (hazard ratio 4.28) and in overweight/obesity (hazard ratio 7.64). However, characterizing this finding as a general doubling of overall 'blindness' requires important context: NAION is a specific and relatively rare form of optic neuropathy, not overall blindness from all causes. Furthermore, the findings stem from retrospective observational data from a single academic neuro-ophthalmology referral center and demonstrate an association rather than proven causality.

2:38:31needs contextmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

In diabetic retinopathies and nephropathies, excess intracellular glucose is diverted into the sorbitol pathway, where sorbitol accumulation creates an osmotic gradient causing hydropic degeneration and cell rupture.

"And if there's so much glycolysis happening that it starts to inhibit entry into the glycolytic pathway, then you divert the glucose into the sorbitol pathway. Now you have glucose turning into sorbitol, which the cell can't do anything with, and so sorbitol begins to accumulate in the cell and that starts to increase the osmotic gradient into the cell. And now you have basically a water balloon that's getting overfull, and you have this what's called hydropic degeneration, where you basically force water into the cell because of this glucose metabolite, and then the cell can burst. And this is a large part of the problem with macular degeneration and retinopathies. In the nephropathies of the kidney, the main mechanism whereby the glucose is damaging, or one of the main mechanisms, is the conversion of the glucose into sorbitol." (said at 2:38:31)

The speaker correctly identifies the polyol (sorbitol) pathway as a key mechanism in hyperglycemia-induced diabetic microvascular complications, including diabetic retinopathy and nephropathy. Under hyperglycemic conditions, excess intracellular glucose is reduced to sorbitol by aldose reductase, leading to intracellular sorbitol accumulation, osmotic swelling/stress, and oxidative stress. However, the claim oversimplifies and conflates aspects of the mechanism: classic osmotic swelling leading to cell rupture (e.g. hydropic changes/cataract formation) was primarily demonstrated in the lens (cataractogenesis) and early polyol research, whereas in diabetic retinopathy and nephropathy, polyol pathway flux causes cellular damage primarily through osmotic stress, oxidative stress (NADPH depletion and altered NADH/NAD+ redox ratio), and downstream inflammatory/metabolic signaling rather than simple physical ballooning and cell rupture. Additionally, the speaker erroneously mentions macular degeneration (age-related macular degeneration is a distinct pathology from diabetic retinopathy, though diabetic macular edema occurs).

2:43:41needs contextmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Glucose-derived polyols such as sorbitol and mannitol cannot passively cross cell membranes.

"these derivatives of glucose, like sorbitol or mannitol, they can't move across cell membranes." (said at 2:43:41)

Glucose-derived polyols like sorbitol and mannitol have very low passive lipid bilayer permeability, which explains why sorbitol accumulates intracellularly during hyperglycemia (causing osmotic stress) and why mannitol acts as an extracellular osmotic agent. However, claiming that they absolutely cannot move across cell membranes requires qualification: several cell types possess carrier-mediated transport mechanisms, including sorbitol permeases, volume-activated channels, and low-affinity transport via hexose transport systems.

2:44:42needs contextmoderateDr. Ben Bikman: How To Reverse Insulin Resistance Through Di

Skeletal muscle tissue does not express glucagon receptors.

"Muscle doesn't have glucagon receptors. Like, it's very much tissue specific." (said at 2:44:42)

Classically and functionally in human physiology, skeletal muscle does not respond to glucagon or express physiologically significant glucagon receptors, which explains why glucagon stimulates glycogenolysis in the liver but not in skeletal muscle. However, stating that muscle completely lacks glucagon receptors requires context: sensitive molecular profiling studies have detected low/basal levels of glucagon receptor (GCGR) mRNA transcripts in skeletal muscle tissue.

Fact-checked episodes

Publications

No PubMed publication profile has been built for this speaker yet.